ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
70 hedge funds and large institutions have $278M invested in Adamas Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
64% less call options, than puts
Call options by funds: $226K | Put options by funds: $634K
Holders
70
Holding in Top 10
3
Calls
$226K
Puts
$634K
Top Buyers
| 1 | +$22.7M | |
| 2 | +$5.74M | |
| 3 | +$4.16M | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.75M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$1.18M |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$2.56M | |
| 3 | -$2.12M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.96M |
| 5 |
Millennium Management
New York
|
-$1.69M |